Efficacy of deferoxamine in animal models of intracerebral hemorrhage: A systematic review and stratified meta-analysis

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Cui, Han Jin ^a   He, Hao Yu ^b   Yang, A Li ^a,c   Zhou, Hua Jun ^c,d   Wang, Cong ^a,c   Luo, Jie Kun ^a,c   Lin, Yuan ^c   Tang, Tao ^a,c  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

^c Key Lab   (China)

^d CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; DEFEROXAMINE; HEMOGLOBIN; ISOFLURANE; PHENOBARBITAL; SIDEROPHORE;

ANESTHESIA; ARTICLE; BRAIN HEMORRHAGE; BRAIN WATER CONTENT; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; EFFECT SIZE; ERYTHROCYTE; FISCHER 344 RAT; NEUROLOGIC EXAMINATION; NEUROPROTECTION; NONHUMAN; SPRAGUE DAWLEY RAT; WATER CONTENT; ANIMAL; CEREBRAL HEMORRHAGE; DISEASE MODEL; MOUSE; PIG; RAT; TREATMENT OUTCOME;

ANIMALIA; RATTUS;

ANIMALS; CEREBRAL HEMORRHAGE; DEFEROXAMINE; DISEASE MODELS, ANIMAL; MICE; RATS; SIDEROPHORES; SWINE; TREATMENT OUTCOME;

EID: 84930619898     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0127256     Document Type: Article

References (49)

1. Sangha N, Gonzales NR. Treatment targets in intracerebral hemorrhage. Neurotherapeutics 2011. 8;374-387. doi: 10.1007/s13311-011-0055-z PMID: 21732225
2. Warkentin LM, Auriat AM, Wowk S, Colbourne F. Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats. Brain Res 2010. 1309;95-103. doi: 10.1016/j.brainres.2009.10.058 PMID: 19879860
3. Wan S, Hua Y, Keep RF, Hoff JT, Xi G. Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage. Acta Neurochir Suppl 2006. 96;199-202. PMID: 16671454
4. Wu J, Hua Y, Keep RF, Nakamura T, Hoff JT, Xi G. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke 2003. 34;2964-2969. PMID: 14615611
5. Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006. 5;53-63. PMID: 16361023
6. Chang CF, Cho S, Wang J. (-)-Epicatechin protects hemorrhagic brain via synergistic Nrf2 pathways. Ann Clin Transl Neurol 2014. 1;258-271. PMID: 24741667
7. Mehdiratta M, Kumar S, Hackney D, Schlaug G, Selim M. Association between serum ferritin level and perihematoma edema volume in patients with spontaneous intracerebral hemorrhage. Stroke 2008. 39;1165-1170. doi: 10.1161/STROKEAHA.107.501213 PMID: 18292378
8. Perez de la Ossa N, Sobrino T, Silva Y, Blanco M, Millan M, Gomis M, et al. Iron-related brain damage in patients with intracerebral hemorrhage. Stroke 2010. 41;810-813. doi: 10.1161/STROKEAHA.109.570168 PMID: 20185788
9. Selim M. Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke 2009. 40;S90-91. doi: 10.1161/STROKEAHA.108.533125 PMID: 19064798
10. Ma J, You C, Hao L. Iron chelators for acute stroke. Cochrane Database Syst Rev 2012. 9;CD009280.
11. Nakamura T, Keep RF, Hua Y, Schallert T, Hoff JT, Xi G. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. Neurosurg Focus 2003. 15;ECP4.
12. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Schallert T, Xi G. Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke 2010. 41;375-382. doi: 10.1161/STROKEAHA.109.569830 PMID: 20044521
13. Okauchi M, Hua Y, Keep RF, Morgenstern LB, Xi G. Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke 2009. 40;1858-1863. doi: 10.1161/STROKEAHA.108.535765 PMID: 19286595
14. Wu H, Wu T, Xu X, Wang J, Wang J. Iron toxicity in mice with collagenase-induced intracerebral hemorrhage. J Cereb Blood Flow Metab 2011. 31;1243-1250. doi: 10.1038/jcbfm.2010.209 PMID: 21102602
15. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA. Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 2008. 39;2824-2829. doi: 10.1161/STROKEAHA.108.515957 PMID: 18635842
16. Sena E, Wheble P, Sandercock P, Macleod M. Systematic review and meta-analysis of the efficacy of tirilazad in experimental stroke. Stroke 2007. 38;388-394. PMID: 17204689
17. Huang FP, Xi G, Keep RF, Hua Y, Nemoianu A, Hoff JT. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J Neurosurg 2002. 96;287-293. PMID: 11838803
18. Manaenko A, Chen H, Kammer J, Zhang JH, Tang J. Comparison Evans Blue injection routes: Intravenous versus intraperitoneal, for measurement of blood-brain barrier in a mice hemorrhage model. J Neurosci Methods 2011. 195;206-210. doi: 10.1016/j.jneumeth.2010.12.013 PMID: 21168441
19. Ropper AH. Lateral displacement of the brain and level of consciousness in patients with an acute hemispheral mass. N Engl J Med 1986. 314;953-958. PMID: 3960059
20. Zazulia AR, Diringer MN, Derdeyn CP, Powers WJ. Progression of mass effect after intracerebral hemorrhage. Stroke 1999. 30;1167-1173. PMID: 10356094
21. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 1999. 30;2752-2758. PMID: 10583007
22. Gibson CL, Gray LJ, Bath PM, Murphy SP. Progesterone for the treatment of experimental brain injury; a systematic review. Brain 2008. 131;318-328. PMID: 17715141
23. Gibson CL, Gray LJ, Murphy SP, Bath PM. Estrogens and experimental ischemic stroke: a systematic review. J Cereb Blood Flow Metab 2006. 26;1103-1113. PMID: 16437060
24. Horn J, de Haan RJ, Vermeulen M, Luiten PG, Limburg M. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 2001. 32;2433-2438. PMID: 11588338
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986. 7;177-188. PMID: 3802833
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997. 315;629-634. PMID: 9310563
27. Xie Q, Gu Y, Hua Y, Liu W, Keep RF, Xi G. Deferoxamine attenuates white matter injury in a piglet intracerebral hemorrhage model. Stroke 2014. 45;290-292. doi: 10.1161/STROKEAHA.113.003033 PMID: 24172580
28. Qing WG, Dong YQ, Ping TQ, Lai LG, Fang LD, Min HW, et al. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4. J Neurosurg 2009. 110;462-468. doi: 10.3171/2008.4.JNS17512 PMID: 19025353
29. Wu J, Wang S, Wen S. The effect of iron on oxidative injury after cerebral hemorrhage. Chin J Emerg Med 2005. 14;563-566.
30. Anderson NE, Broad JB, Bonita R. Delays in hospital admission and investigation in acute stroke. BMJ 1995. 311;162. PMID: 7613428
31. Yeatts SD, Palesch YY, Moy CS, Selim M. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care 2013. 19;257-266. doi: 10.1007/s12028-013-9861-y PMID: 23943316
32. Markowitz GJ, Kadam SD, Smith DR, Johnston MV, Comi AM. Different effects of high- and low-dose phenobarbital on post-stroke seizure suppression and recovery in immature CD1 mice. Epilepsy Res 2011. 94;138-148. doi: 10.1016/j.eplepsyres.2011.01.002 PMID: 21481568
33. Barks JD, Liu YQ, Shangguan Y, Silverstein FS. Phenobarbital augments hypothermic neuroprotection. Pediatr Res 2010. 67;532-537. doi: 10.1203/PDR.0b013e3181d4ff4d PMID: 20098339
34. Wang J. Preclinical and clinical research on inflammation after intracerebral hemorrhage. Prog Neurobiol 2010. 92;463-477. doi: 10.1016/j.pneurobio.2010.08.001 PMID: 20713126
35. Xi G, Keep RF, Hoff JT. Erythrocytes and delayed brain edema formation following intracerebral hemorrhage in rats. J Neurosurg 1998. 89;991-996. PMID: 9833826
36. Gong Y, Hua Y, Keep RF, Hoff JT, Xi G. Intracerebral hemorrhage: effects of aging on brain edema and neurological deficits. Stroke 2004. 35;2571-2575. PMID: 15472083
37. Wu H, Wu T, Li M, Wang J. Efficacy of the lipid-soluble iron chelator 2,2′-dipyridyl against hemorrhagic brain injury. Neurobiol Dis 2012. 45;388-394. doi: 10.1016/j.nbd.2011.08.028 PMID: 21930208
38. O'Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010. 376;112-123. doi: 10.1016/S0140-6736(10)60834-3 PMID: 20561675
39. Emerging Risk Factors C, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010. 375;2215-2222. doi: 10.1016/S0140-6736(10)60484-9 PMID: 20609967
40. Jin L. The effect of the iron chelator on brain edema after experimental intracerebral hemorrhage: Zhejiang University 2004.
41. Hua Y, Nakamura T, Keep RF, Wu J, Schallert T, Hoff JT, et al. Long-term effects of experimental intracerebral hemorrhage: the role of iron. J Neurosurg 2006. 104;305-312. PMID: 16848086
42. Bao X, Wu G, Hu S, Huang F. Poly(ADP-ribose) polymerase activation and brain edema formation by hemoglobin after intracerebral hemorrhage in rats. Acta Neurochir Suppl 2008. 105;23-27. PMID: 19066076
43. Liu S, Li C. Study on injury in brain parenchyma surrounding intracebral hemorrhage induced by iron ions Journal of Chongqing Medical University 2008. 33;700-703.
44. Wan S, Zhan R, Zheng S, Hua Y, Xi G. Activation of c-Jun-N-terminal kinase in a rat model of intracerebral hemorrhage: the role of iron. Neurosci Res 2009. 63;100-105. doi: 10.1016/j.neures.2008.10.013 PMID: 19100788
45. Qiu X. Effect of deferoxamine on glucose metabolism on rat model of intracerebral hemorrhage: Zhejiang University 2010.
46. Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces cavity size in the brain after intracerebral hemorrhage in aged rats. Acta Neurochir Suppl 2011. 111;185-190. doi: 10.1007/978-3-7091-0693-8-31 PMID: 21725753
47. Auriat AM, Silasi G, Wei Z, Paquette R, Paterson P, Nichol H, et al. Ferric iron chelation lowers brain iron levels after intracerebral hemorrhage in rats but does not improve outcome. Exp Neurol 2012. 234;136-143. doi: 10.1016/j.expneurol.2011.12.030 PMID: 22226595
48. Chun HJ, Kim DW, Yi HJ, Kim YS, Kim EH, Hwang SJ, et al. Effects of statin and deferoxamine administration on neurological outcomes in a rat model of intracerebral hemorrhage. Neurol Sci 2012. 33;289-296. doi: 10.1007/s10072-011-0733-y PMID: 21863269
49. Hatakeyama T, Okauchi M, Hua Y, Keep RF, Xi G. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res 2013. 4;546-553. doi: 10.1007/s12975-013-0270-5 PMID: 24187595